Meloxicam Capsule (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Meloxicam 7.5 mg is administered orally once daily. If symptoms do not improve, the dose may be increased to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: This drug 15 mg is administered orally once daily. The dose may be reduced to 7.5 mg daily according to response to treatment. This drug should not be administered at doses exceeding 15 mg per day and should be taken with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg per day. ○ Patients with severe renal failure undergoing hemodialysis should not receive more than 7.5 mg per day.

This medication may pose a risk of gastrointestinal bleeding for individuals who consume alcohol regularly, particularly in amounts exceeding three drinks a day, so it is essential to consult with a physician or pharmacist. This medication can cause cardiovascular issues, and patients at risk for heart disease or stroke should be particularly cautious; if symptoms such as chest pain or shortness of breath occur, the medication should be discontinued immediately. It can lead to severe gastrointestinal problems such as gastrointestinal bleeding, ulcers, or perforation, so individuals with a history of gastrointestinal diseases or the elderly should use it with more caution. Severe allergic reactions or life-threatening hypersensitivity reactions such as anaphylaxis can occur; therefore, if unusual symptoms such as skin rash or mucosal damage arise, the medication should be discontinued immediately. This medication may affect kidney and liver function, and patients with kidney or liver issues should consult a physician before taking the medication and undergo regular function tests during treatment. Women who are pregnant or planning to become pregnant should not take this medication, as caution is needed due to a possibility of decreased reproductive capacity. Patients with a specific allergy or hypersensitivity history, gastrointestinal bleeding or ulcers, severe liver or kidney dysfunction, heart failure, and hypertension should not take this medication. Elderly patients, being more susceptible to side effects due to weaker physiological function, should use the minimum dose cautiously. This medication may interact with other drugs; therefore, if you are currently taking other medications, you must inform your physician or pharmacist. In case of overdose, symptoms such as drowsiness, nausea, and gastrointestinal bleeding may occur, and immediate medical treatment should be sought. This medication should be kept out of the reach of children, and it should be stored in its original container to prevent misuse or degradation of quality.

• Gastrointestinal hemorrhage
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• bleeding of the stomach or intestines
• ulcers
• perforation
• exfoliative dermatitis
• mucous membrane syndrome
• toxic epidermal necrolysis

This medication should be stored in a tightly sealed container that protects it from light and at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the drug's efficacy and safety.

Appearance

Dark green capsules containing a yellowish powder.

Package unit

30 capsules/bottle, 300 capsules/bottle